Deenz Psychopathy Spectrum Scale (DPSS)
normative dataset currently contains
1389
participant records collected between
Jun 11, 2026
and
Aug 7, 2026
.
This psychometric dataset currently includes 1389 anonymous participant responses collected through voluntary participation. The observed mean score was 51.79 with a standard deviation of 16.37, indicating moderate score variability within the sampled population. Internal consistency reliability analysis demonstrated good reliability (Cronbach alpha = 0.851). Observed skewness (-0.15) and kurtosis (-0.22) were examined as indicators of distribution quality. The score distribution appeared reasonably balanced and did not suggest substantial departures from normality.
1389
Participants
79
Countries
24
Scale Items
0.851
Reliability
Table 1
Dataset Overview
Assessment
Deenz Psychopathy Spectrum Scale (DPSS)
Research Status
Robust Dataset
Dataset Maturity
95
/100 —
ROBUST
Participants
1389
Countries Represented
79
Items
24
Dimensions
6
Data Collection Period
Jun 11, 2026
–
Aug 7, 2026
Reliability
α =
0.851
Note.
The current Deenz Psychopathy Spectrum Scale (DPSS) dataset contains 1389 participant records collected from 79 countries. Dataset maturity reflects sample size, geographic diversity, and internal consistency reliability.
Table 2
Descriptive Statistics
Statistic
Value
Mean Score
51.79%
Median Score
52
Standard Deviation
16.37
Variance
268.1
Standard Error
0.44
95% CI Lower
50.93
95% CI Upper
52.65
Minimum Score
0%
Maximum Score
92%
Observed Range
92
Note.
M = 51.79, SD = 16.37, Median = 52. The 95% confidence interval ranged from 50.93 to 52.65.
Table 3
Sample Characteristics
Variable
Summary
Participants
N =
1389
Countries
79
Age Information
Available
Gender Information
Available
Note.
Demographic information was collected voluntarily. Participant counts may vary across demographic categories when information was not reported.
Age Distribution
Age Group
Participants
18-24
249
under18
242
25-34
133
prefer_not
131
35-44
71
45-54
31
55plus
17
Gender Distribution
Gender
Participants
Male
465
Female
381
Prefer_not
28
Figure 1
Global Participation
Note.
Participants were represented across 79 countries. The largest contribution originated from BR (38.5% of available geographic records).
Country
Participants
Percent
BR
535
38.5%
US
170
12.2%
IN
144
10.4%
FR
121
8.7%
DE
50
3.6%
ES
47
3.4%
GB
22
1.6%
MX
20
1.4%
AU
19
1.4%
CA
15
1.1%
PH
15
1.1%
NL
11
0.8%
CL
10
0.7%
AR
10
0.7%
IT
9
0.6%
BE
9
0.6%
T1
9
0.6%
CO
8
0.6%
IE
8
0.6%
AT
8
0.6%
AE
7
0.5%
FI
7
0.5%
ID
6
0.4%
SE
5
0.4%
SG
5
0.4%
UA
5
0.4%
PT
5
0.4%
DK
5
0.4%
EC
5
0.4%
PL
4
0.3%
CN
4
0.3%
GE
4
0.3%
CH
4
0.3%
VE
3
0.2%
PY
3
0.2%
MA
3
0.2%
GR
3
0.2%
NO
3
0.2%
CU
3
0.2%
CZ
3
0.2%
SV
3
0.2%
MG
3
0.2%
HU
3
0.2%
JP
3
0.2%
TH
2
0.1%
RU
2
0.1%
EE
2
0.1%
DO
2
0.1%
LT
2
0.1%
TN
2
0.1%
RS
2
0.1%
BO
2
0.1%
ZA
2
0.1%
TG
2
0.1%
KG
2
0.1%
HR
2
0.1%
SA
2
0.1%
BA
2
0.1%
VN
2
0.1%
KE
1
0.1%
MT
1
0.1%
PE
1
0.1%
IL
1
0.1%
LK
1
0.1%
TR
1
0.1%
RE
1
0.1%
MM
1
0.1%
MN
1
0.1%
AO
1
0.1%
MV
1
0.1%
UY
1
0.1%
EG
1
0.1%
SK
1
0.1%
LV
1
0.1%
PA
1
0.1%
ML
1
0.1%
KR
1
0.1%
RO
1
0.1%
HK
1
0.1%
Table 4
Percentile Norms
Percentile
Score
Interpretation
10th
30%
Very Low
25th
41%
Below Average
50th
52%
Average
75th
64%
Above Average
90th
74%
Elevated
Note.
Percentile values provide preliminary normative benchmarks derived from the current Deenz Psychopathy Spectrum Scale (DPSS) sample.
Figure 2
Score Distribution
Note.
Observed scores ranged from 0% to 92% (M = 51.79, SD = 16.37). Distribution characteristics included skewness (-0.15) and kurtosis (-0.22).
Distribution indices suggested no substantial departures from normality.
Table 5
Reliability Analysis
Metric
Value
Cronbach Alpha
0.851
Reliability Classification
Good
Participants
1389
Items
24
Standard Error
0.44
Note.
Internal consistency was estimated using Cronbach alpha. Reliability estimates are based on the current normative dataset and may change as additional responses are collected.
Item–Total Correlations
Item Analysis Interpretation
Item–total correlations were generally strong across the assessment, indicating that most items contribute effectively to the measurement of the underlying construct.
The analysis identified6
itemsthat may benefit from future review.
Items Recommended for Future Review
Q1
(r = 0.02)
I am able to resolve conflicts in a peaceful manner.
Q2
(r = -0.01)
I am the type of person who tries my best to avoid making threatening language or aggressive statements.
Q19
(r = 0.12)
If I compare myself to others, these comparisons make me feel worse about myself.
Q21
(r = 0.18)
I always maintain my composure and remain calm even in stressful situations.
Q22
(r = 0.02)
I lack the ability to attract and influence others.
Q24
(r = 0.18)
I often lose interest when listening to someone talk about their problems.
The lowest item–total correlation was observed for Q2 ("I am the type of person who tries my best to avoid making threatening language or aggressive statements."; r = -0.01), indicating comparatively weaker alignment with the overall construct.
Table 7
Dimension Norms
Dimension
Mean
SD
N
Callousness
62%
25.23
1389
Manipulation
58.88%
25.71
1389
Impulsivity
54.67%
26.04
1389
Ego
54.4%
18.47
1389
Aggression
45.85%
21.53
1389
Glibness
36.43%
15.98
1389
Note.
Dimension statistics summarize normative performance across the major constructs measured by Deenz Psychopathy Spectrum Scale (DPSS).
Figure 5
Dimension Profile
Note.
The highest observed dimension was Callousness (62%), whereas the lowest observed dimension was Glibness (36.4%). The observed difference between dimensions was 25.6 percentage points. Substantial variation was observed between dimensions.
Table 8
Dataset Growth Summary
Metric
Value
Current Participants
1389
Countries
79
Collection Start
Jun 11, 2026
Collection End
Aug 7, 2026
Months Recorded
3
Note.
Growth statistics summarize cumulative participation throughout the observed data collection period.
Normative Data Notice
A total of
1389
participant responses were available for this assessment.
Dimension-level norms were calculated using
1389
valid response records.
Approximately
0
response record(s) were excluded from dimension-level normative calculations due to incomplete response patterns.
Limitations
Normative statistics are derived from voluntary participation and may not represent all populations. Reliability estimates, percentile norms, and dimension statistics should be interpreted in the context of the current sample and may change as additional responses are collected.
Ethical Statement
All records included in this dataset were collected anonymously. No personally identifying information is stored. Data are intended for educational, psychometric, and research purposes.
Recommended Citation
Deenz Psychopathy Spectrum Scale (DPSS). Research Dataset. Retrieved from https://drdeenz.com/psychopathy-spectrum-test/statistics/